Brief: Biosergen Q3 EBITDA SEK -12.19 Million
19/11/2025 07:31
Nov 19 (Reuters) - Biosergen Q3 EPS SEK -0.05. Q3 adjusted EBIT SEK -12.19 million Q3 net income SEK -12.168 million
BIOSGN — Biosergen AB News Story
0.000.00%
Last trade - 00:00- SEK17.61m
- -SEK5.10m